Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MCLA-117 |
Synonyms | |
Therapy Description |
Tepoditamab (MCLA-117) is a bispecific antibody that targets CLEC12A and CD3, which potentially results in an increased T-cell response against CLEC12A-expressing tumor cells and tumor cell lysis (PMID: 31286786). |